Virtual Library

 x 
My Library Virtual Library FAQ

Start Your Search

  • WCLC 2018

    19th World Conference on Lung Cancer

    Access to all presentations that occur during the 19th World Conference on Lung Cancer in Toronto, ON

    Presentation Date(s):  
    • Sept 23 - 26, 2018
    • Total Presentations: 2384

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

    Presentations will be available 24 hours after their live presentation time

    IASLC Member Price: $0.00 USD
    Enter Virtual Meeting Access Code
Filter Results:

Show Only Available Presentations

  • +

    P1.01 - Advanced NSCLC (Not CME Accredited Session)

    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 112
    • Coordinates: 9/24/2018, 16:45 - 18:00, Exhibit Hall
    • +

      P1.01-70 - Efficacy and Safety of Second- or Third-Line Nab-Paclitaxel + Durvalumab in Patients with Advanced NSCLC (ABOUND.2L+)

      16:45 - 18:00  |  Presenter: Daniel Morgensztern

      • Abstract

      Loading...

    • +

      P1.01-93 - Quality of Life in Patients with Advanced NSCLC Treated in Second- or Third-Line with Nab-Paclitaxel + Durvalumab: ABOUND.2L+

      16:45 - 18:00  |  Author(s): Denis Talbot

      • Abstract

      Loading...

  • +

    MTE15 - Who is Too High Risk for a VATS Resection? (Ticketed Session)

    • Type: Meet the Expert Session
    • Track: Treatment of Early Stage/Localized Disease
    • Presentations: 2
    • Coordinates: 9/25/2018, 07:00 - 08:00, Room 205 BD
  • +

    MA25 - Oligometastasis: Defining, Treating, and Evaluating

    • Type: Mini Oral Abstract Session
    • Track: Oligometastatic NSCLC
    • Presentations: 12
    • Coordinates: 9/26/2018, 13:30 - 15:00, Room 203 BD
  • +

    MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1

    • Type: Mini Oral Abstract Session
    • Track: Targeted Therapy
    • Presentations: 12
    • Coordinates: 9/26/2018, 13:30 - 15:00, Room 201 BD
    • +

      MA26.06 - Crizotinib-Treated ALK Immunopositive Metastasized NSCLC is Associated with an Unfavorable Prognosis when FISH Negative 

      14:05 - 14:10  |  Presenter: Erik Thunnissen

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.